CAS 1329796-53-3

Entecavir-13C2,15N

Producto controlado

CAS: 1329796-53-3

Applications Labelled Entecavir. An oral antiviral drug used in the treatment of hepatitis B infection. A guanine analogue that inhhibits all three steps in the viral replication process.
References Innaimo, S.F., et al.: Antimicrob. Agents Chemother., 41, 1444 (1997), Honkoop, P., et al.: Expert Opin. Invest. Drugs, 12, 683 (2003), Chang, T.-T., et al.: N. Engl. J. Med., 354, 1001 (2006),

Fórmula: C₁₀₁₃C₂H₁₅N₄₁₅NO₃

Forma y color: White To Off-White

Peso molecular: 280.26

Ref: TR-E558902

Entecavir-13C2,15N

CAS: 1329796-53-3

Entecavir-13C2,15N is an isotopically labeled antiviral agent, which is a synthetic nucleoside analogue derived from natural sources. Its mode of action involves selectively inhibiting the reverse transcription activity of the hepatitis B virus (HBV) polymerase. By mimicking the natural substrates of the viral polymerase, Entecavir-13C2,15N becomes incorporated into viral DNA, ultimately leading to chain termination and suppression of viral replication.

Fórmula: C₁₂H₁₅N₅O₃

Pureza: Min. 95%

Peso molecular: 280.26 g/mol

Ref: 3D-EDC79653